
Global Structural Heart Imaging Market Report and Forecast 2024-2032
Description
Global Structural Heart Imaging Market Report and Forecast 2024-2032
Global Structural Heart Imaging Market Report and Forecast 2017-2032
The global structural heart imaging market size was valued at USD 17.4 billion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 10.11% reaching a value of USD 41.3 billion by 2032. The major factors driving the growth of the global structural heart imaging market are the increasing prevalence of structural heart diseases, the rising adoption of minimally invasive therapies, the technological advancements in imaging modalities, and the growing geriatric population.
Structural heart imaging refers to the use of various imaging modalities, such as echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging, to diagnose and monitor the structural abnormalities of the heart, such as valvular diseases, congenital defects, and cardiomyopathies. Structural heart imaging plays a vital role in the planning and guidance of minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and left atrial appendage closure (LAAC).
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for 17.9 million deaths in 2019. Among CVDs, structural heart diseases, such as aortic stenosis, mitral regurgitation, and atrial septal defect, affect millions of people worldwide and pose a significant burden on the healthcare system. The demand for structural heart imaging is expected to increase as more patients seek early diagnosis and treatment of these conditions.
However, the global structural heart imaging market also faces some challenges, such as the high cost and complexity of imaging equipment, the lack of skilled and trained professionals, the stringent regulatory environment, and the reimbursement issues in some regions. These factors may hamper market growth to some extent during the forecast period.
Global Structural Heart Imaging Market Drivers and Constraints
Market Drivers
- The increasing prevalence of structural heart diseases, such as aortic stenosis, mitral regurgitation, and atrial septal defect, which require early diagnosis and treatment to prevent complications and mortality.
- The rising adoption of minimally invasive therapies, such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and left atrial appendage closure (LAAC), which offer less morbidity, shorter hospital stay, and better outcomes than open-heart surgery.
- The technological advancements in imaging modalities, such as echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging, which enable high-resolution, three-dimensional, and real-time visualization of the cardiac structures and function.
- The growing geriatric population, which is more prone to develop structural heart diseases due to aging-related changes in the cardiac valves and tissues.
- The high cost and complexity of imaging equipment, which may limit the accessibility and affordability of structural heart imaging, especially in low- and middle-income countries.
- The lack of skilled and trained professionals, such as cardiologists, radiologists, and sonographers, who can perform and interpret structural heart imaging accurately and efficiently.
- The stringent regulatory environment, which may pose challenges for the approval and market entry of new and innovative imaging devices and software.
- The reimbursement issues in some regions may affect the adoption and utilization of structural heart imaging, especially for novel and expensive procedures.
The global structural heart imaging market has been experiencing several key trends in recent years, driven by advancements in technology, increasing prevalence of structural heart diseases, and a growing emphasis on early and accurate diagnosis. Here are some of the latest market trends:
- Advancements in Imaging Technologies: There has been significant progress in imaging technologies such as echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI). 3D imaging, for instance, provides detailed views of heart structures, facilitating better diagnosis and treatment planning.
- Integration of Artificial Intelligence (AI): AI and machine learning are increasingly being integrated into structural heart imaging systems. AI algorithms can assist in automating image analysis, improving accuracy, and reducing diagnosis time.
- Minimally Invasive Procedures: The rise in minimally invasive procedures for treating structural heart diseases, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), is driving the demand for precise imaging techniques to guide these procedures.
- Portable and Handheld Devices: There is a growing trend towards the development of portable and handheld imaging devices. These devices are especially useful in remote areas and for point-of-care diagnostics.
- Focus on Personalized Medicine: Personalized treatment plans based on detailed structural heart imaging are becoming more common. This approach ensures that patients receive tailored therapies that are most likely to be effective for their specific condition.
- Collaboration between Industry and Healthcare Providers: Partnerships between imaging technology companies and healthcare providers are increasing, aiming to develop innovative solutions and improve patient outcomes.
- Expansion in Emerging Markets: The structural heart imaging market is expanding in emerging economies due to increasing awareness of heart diseases, improving healthcare infrastructure, and rising healthcare expenditures.
- Regulatory Approvals for Advanced Systems: Regulatory approvals for new and advanced imaging systems are accelerating their adoption in clinical practice. These systems offer enhanced resolution and clearer images for better diagnosis and treatment planning.
Global Structural Heart Imaging Market Segmentation
Market Breakup by Imaging Modality
- Echocardiography (2D and 3D)
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Angiography (including Transesophageal Echocardiography)
- Nuclear Imaging
- Others
- Valvular Heart Disease
- Congenital Heart Disease
- Cardiomyopathy
- Others
- 2D Imaging
- 3D Imaging
- 4D Imaging
- Doppler Imaging
- Contrast Imaging
- Stress Testing
- Transthoracic Echocardiogram (TTE)
- Transesophageal Echocardiogram (TEE)
- Cardiac Catheterization
- Others
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The global structural heart imaging market is highly competitive and fragmented, with the presence of several large and small players. The key players in the market are focusing on product innovation, strategic partnerships, mergers and acquisitions, and geographic expansion to gain a competitive edge and increase their market share.
Some of the key players and recent developments in the market are General Electric Company (GE Healthcare), Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi, Ltd., Shimadzu Corporation, Esaote S.p.A., FUJIFILM Holdings Corporation, Samsung Medison Co., Ltd., Carestream Health, Inc., Toshiba Corporation (Canon Medical Systems), ESAOTE SPA, Mindray Medical International Limited, Pie Medical Imaging, and 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging).
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Structural Heart Imaging Market Overview
- 3.1 Global Structural Heart Imaging Market Historical Value (2017-2023)
- 3.2 Global Structural Heart Imaging Market Forecast Value (2024-2032)
- 4 Global Structural Heart Imaging Market Landscape*
- 4.1 Global Structural Heart Imaging: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Structural Heart Imaging: Product Landscape
- 4.2.1 Analysis by Imaging Modality
- 4.2.2 Analysis by Application
- 5 Global Structural Heart Imaging Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Structural Heart Imaging Market Segmentation (2017-2032)
- 6.1 Global Structural Heart Imaging Market (2017-2032) by Imaging Modality
- 6.1.1 Market Overview
- 6.1.2 Echocardiography (2D and 3D)
- 6.1.3 Magnetic Resonance Imaging (MRI)
- 6.1.4 Computed Tomography (CT)
- 6.1.5 Angiography (including Transesophageal Echocardiography)
- 6.1.6 Nuclear Imaging
- 6.1.7 Others
- 6.2 Global Structural Heart Imaging Market (2017-2032) by Application
- 6.2.1 Market Overview
- 6.2.2 Valvular Heart Disease
- 6.2.3 Congenital Heart Disease
- 6.2.4 Cardiomyopathy
- 6.2.5 Others
- 6.3 Global Structural Heart Imaging Market (2017-2032) by Technology
- 6.3.1 Market Overview
- 6.3.2 2D Imaging
- 6.3.3 3D Imaging
- 6.3.4 4D Imaging
- 6.3.5 Doppler Imaging
- 6.3.6 Contrast Imaging
- 6.4 Global Structural Heart Imaging Market (2017-2032) by Test Type
- 6.4.1 Market Overview
- 6.4.2 Stress Testing
- 6.4.3 Transthoracic Echocardiogram (TTE)
- 6.4.4 Transesophageal Echocardiogram (TEE)
- 6.4.5 Cardiac Catheterization
- 6.4.6 Others
- 6.5 Global Structural Heart Imaging Market (2017-2032) by End User
- 6.5.1 Hospitals
- 6.5.2 Diagnostic Imaging Centers
- 6.5.3 Ambulatory Surgical Centers
- 6.5.4 Others
- 6.6 Global Structural Heart Imaging Market (2017-2032) by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Structural Heart Imaging Market (2017-2032)
- 7.1 North America Structural Heart Imaging Market (2017-2032) by Imaging Modality
- 7.1.1 Market Overview
- 7.1.2 Echocardiography (2D and 3D)
- 7.1.3 Magnetic Resonance Imaging (MRI)
- 7.1.4 Computed Tomography (CT)
- 7.1.5 Angiography (including Transesophageal Echocardiography)
- 7.1.6 Nuclear Imaging
- 7.1.7 Others
- 7.2 North America Structural Heart Imaging Market (2017-2032) by Application
- 7.2.1 Market Overview
- 7.2.2 Valvular Heart Disease
- 7.2.3 Congenital Heart Disease
- 7.2.4 Cardiomyopathy
- 7.2.5 Others
- 7.3 North America Structural Heart Imaging Market (2017-2032) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Structural Heart Imaging Market (2017-2032)
- 8.1 Europe Structural Heart Imaging Market (2017-2032) by Imaging Modality
- 8.1.1 Market Overview
- 8.1.2 Echocardiography (2D and 3D)
- 8.1.3 Magnetic Resonance Imaging (MRI)
- 8.1.4 Computed Tomography (CT)
- 8.1.5 Angiography (including Transesophageal Echocardiography)
- 8.1.6 Nuclear Imaging
- 8.1.7 Others
- 8.2 Europe Structural Heart Imaging Market (2017-2032) by Application
- 8.2.1 Market Overview
- 8.2.2 Valvular Heart Disease
- 8.2.3 Congenital Heart Disease
- 8.2.4 Cardiomyopathy
- 8.2.5 Others
- 8.3 Europe Structural Heart Imaging Market (2017-2032) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Structural Heart Imaging Market (2017-2032)
- 9.1 Asia Pacific Structural Heart Imaging Market (2017-2032) by Imaging Modality
- 9.1.1 Market Overview
- 9.1.2 Echocardiography (2D and 3D)
- 9.1.3 Magnetic Resonance Imaging (MRI)
- 9.1.4 Computed Tomography (CT)
- 9.1.5 Angiography (including Transesophageal Echocardiography)
- 9.1.6 Nuclear Imaging
- 9.1.7 Others
- 9.2 Asia Pacific Structural Heart Imaging Market (2017-2032) by Application
- 9.2.1 Market Overview
- 9.2.2 Valvular Heart Disease
- 9.2.3 Congenital Heart Disease
- 9.2.4 Cardiomyopathy
- 9.2.5 Others
- 9.3 Asia Pacific Structural Heart Imaging Market (2017-2032) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Australia
- 9.3.6 Others
- 10 Latin America Structural Heart Imaging Market (2017-2032)
- 10.1 Latin America Structural Heart Imaging Market (2017-2032) by Imaging Modality
- 10.1.1 Market Overview
- 10.1.2 Echocardiography (2D and 3D)
- 10.1.3 Magnetic Resonance Imaging (MRI)
- 10.1.4 Computed Tomography (CT)
- 10.1.5 Angiography (including Transesophageal Echocardiography)
- 10.1.6 Nuclear Imaging
- 10.1.7 Others
- 10.2 Latin America Structural Heart Imaging Market (2017-2032) by Application
- 10.2.1 Market Overview
- 10.2.2 Valvular Heart Disease
- 10.2.3 Congenital Heart Disease
- 10.2.4 Cardiomyopathy
- 10.2.5 Others
- 10.3 Latin America Structural Heart Imaging Market (2017-2032) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Structural Heart Imaging Market (2017-2032)
- 11.1 Middle East and Africa Structural Heart Imaging Market (2017-2032) by Imaging Modality
- 11.1.1 Market Overview
- 11.1.2 Echocardiography (2D and 3D)
- 11.1.3 Magnetic Resonance Imaging (MRI)
- 11.1.4 Computed Tomography (CT)
- 11.1.5 Angiography (including Transesophageal Echocardiography)
- 11.1.6 Nuclear Imaging
- 11.1.7 Others
- 11.2 Middle East and Africa Structural Heart Imaging Market (2017-2032) by Application
- 11.2.1 Market Overview
- 11.2.2 Valvular Heart Disease
- 11.2.3 Congenital Heart Disease
- 11.2.4 Cardiomyopathy
- 11.2.5 Others
- 11.3 Middle East and Africa Structural Heart Imaging Market (2017-2032) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 General Electric Company (GE Healthcare)
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Siemens Healthineers AG
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Koninklijke Philips N.V.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Canon Medical Systems Corporation
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Hitachi, Ltd.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Shimadzu Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Esaote S.p.A.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 FUJIFILM Holdings Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Samsung Medison Co., Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Carestream Health, Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Toshiba Corporation (Canon Medical Systems)
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 ESAOTE SPA
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Mindray Medical International Limited
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Pie Medical Imaging
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging)
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- List not exhaustive
- 18 Global Structural Heart Imaging Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.